Literature DB >> 21369890

Docking studies towards exploring antiviral compounds against envelope protein of yellow fever virus.

Amineni Umamaheswari1, Manne Muni Kumar, Dibyabhaba Pradhan, Hemanthkumar Marisetty.   

Abstract

Yellow fever is among one of the most lethal viral diseases for which approved antiviral therapies were yet to be discovered. Herein, functional assignment of complete YFV proteome was done through support vector machine. Major envelope (E) protein that mediates entry of YFV into host cell was selected as a potent molecular target. Three dimensional structure of the molecular target was predicted using Modeller9v7. The model was optimized in Maestro9.0 applying OPLS AA force field and was evaluated using PROCHECK, ProSA, ProQ and Profile 3D. The BOG pocket residues Val48, Glu197, Thr200, Ile204, Thr265, Thr268 and Gly278 were located in YFV E protein using SiteMap2.3. More than one million compounds of Ligandinfo Meta database were explored using a computational virtual screening protocol targeting BOG pocket of the E protein. Finally, ten top ranked lead molecules with strong binding affinity to BOG pocket of YFV E protein were identified based on XP Gscore. Drug likeliness and comparative bioactivity analysis for these leads using QikProp3.2 had shown that these molecules would have the potential to act as better drug. Thus, the 10 lead molecules suggested in the present study would be of interest as promising starting point for designing antiviral compound against yellow fever.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21369890     DOI: 10.1007/s12539-011-0064-y

Source DB:  PubMed          Journal:  Interdiscip Sci        ISSN: 1867-1462            Impact factor:   2.233


  8 in total

Review 1.  Experimental therapies for yellow fever.

Authors:  Justin G Julander
Journal:  Antiviral Res       Date:  2012-12-10       Impact factor: 5.970

2.  Rational design of 9-vinyl-phenyl noscapine as potent tubulin binding anticancer agent and evaluation of the effects of its combination on Docetaxel.

Authors:  Shruti Gamya Dash; Charu Suri; Praveen Kumar Reddy Nagireddy; Srinivas Kantevari; Pradeep Kumar Naik
Journal:  J Biomol Struct Dyn       Date:  2020-07-01

3.  In Silico Drug Discovery for Treatment of Virus Diseases.

Authors:  Shikha Joon; Rajeev K Singla; Bairong Shen
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

4.  Frog skin cultures secrete anti-yellow fever compounds.

Authors:  Carolina Muñoz-Camargo; Margarita Correa Méndez; Vivian Salazar; Johanna Moscoso; Diana Narváez; Maria Mercedes Torres; Franz Kaston Florez; Helena Groot; Eduardo Mitrani
Journal:  J Antibiot (Tokyo)       Date:  2016-04-06       Impact factor: 2.649

5.  Integrating sampling techniques and inverse virtual screening: toward the discovery of artificial peptide-based receptors for ligands.

Authors:  Germán M Pérez; Luis A Salomón; Luis A Montero-Cabrera; José M García de la Vega; Marcello Mascini
Journal:  Mol Divers       Date:  2015-11-09       Impact factor: 2.943

Review 6.  What Does the Future Hold for Yellow Fever Virus? (II).

Authors:  Raphaëlle Klitting; Carlo Fischer; Jan F Drexler; Ernest A Gould; David Roiz; Christophe Paupy; Xavier de Lamballerie
Journal:  Genes (Basel)       Date:  2018-08-21       Impact factor: 4.096

7.  Identification of Potential HCV Inhibitors Based on the Interaction of Epigallocatechin-3-Gallate with Viral Envelope Proteins.

Authors:  Fareena Shahid; Roshan Ali; Syed Lal Badshah; Syed Babar Jamal; Riaz Ullah; Ahmed Bari; Hafiz Majid Mahmood; Muhammad Sohaib; Siddique Akber Ansari
Journal:  Molecules       Date:  2021-02-26       Impact factor: 4.411

8.  In silico virtual screening approaches for anti-viral drug discovery.

Authors:  Manuela S Murgueitio; Marcel Bermudez; Jérémie Mortier; Gerhard Wolber
Journal:  Drug Discov Today Technol       Date:  2012
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.